Page last updated: 2024-11-05

ticlopidine and Depression

ticlopidine has been researched along with Depression in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fihn, SD1
Gardin, JM1
Abrams, J1
Berra, K1
Blankenship, JC1
Dallas, AP1
Douglas, PS1
Foody, JM1
Gerber, TC1
Hinderliter, AL1
King, SB1
Kligfield, PD1
Krumholz, HM1
Kwong, RY1
Lim, MJ1
Linderbaum, JA1
Mack, MJ1
Munger, MA1
Prager, RL1
Sabik, JF1
Shaw, LJ1
Sikkema, JD1
Smith, CR1
Smith, SC1
Spertus, JA1
Williams, SV1
Tibold, A1
Feher, G1
Csejtei, A1
Tettinger, A1
Kiss, I1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline[NCT03067402]1,100 participants (Anticipated)Interventional2017-03-20Not yet recruiting
Register of Cardiovascular Complications Among People Living With HIV[NCT02453919]800 participants (Anticipated)Observational [Patient Registry]2010-02-28Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for ticlopidine and Depression

ArticleYear
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the
    Journal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24

    Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight

2012
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the
    Journal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24

    Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight

2012
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the
    Journal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24

    Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight

2012
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the
    Journal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24

    Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight

2012
Selective serotonin reuptake inhibitors may interfere with the antiplatelet effect of clopidogrel.
    The American journal of cardiology, 2007, Apr-01, Volume: 99, Issue:7

    Topics: Antidepressive Agents, Second-Generation; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disea

2007